About Strategy Industry Focus Portfolio Team Contact Investor Login HEALTHCARE Medpace CINCINNATI, OHIO FOUNDED in 1992, Medpace is a global, late-stage focused clinical research organization (“CRO”) providing a comprehensive suite of clinical trial services to pharmaceutical, biotech and medical device companies. Medpace also provides complementary laboratory, human pharmacology and imaging lab services. VIEW GROWTH STORY MEDPACE.COM ORIGINAL INVESTMENT 2011 FUND CCMP II STATUS Realized Partnered with an experienced founder-led management team in the rapidly expanding clinical research industry to expand international capabilities and add new therapeutic areas leading to significant revenue and EBITDA growth and successful sale of the company in 2014 CEO CORNER “CCMP added value throughout our partnership and steadfastly supported our commitment to growing the business. With their expertise and invaluable strategic insight, CCMP has been vital to Medpace’s expansion and helped to shape our very promising direction for the future.” – 2014 AUGUST TROENDLE, PRESIDENT & CEO GROWTH PLAN Expanded international capabilities Increased share in core therapeutic areas Developed capabilities in new therapeutic areas Completed opportunistic bolt-on acquisition Terms of Use and Disclaimers Privacy Notice © 2021 CCMP Capital Advisors, LP. All rights reserved.

About Strategy Industry Focus Portfolio Team Contact Investor Login INDUSTRY FOCUS Industrial Industry Focus Consumer Healthcare Industrial CCMP Capital has invested over $7 billion in industrial companies over 35 years in sub-sectors including: Industrial & Home Automation Specialty chemicals Packaging Distribution Industrial services CCMP Industrial Team: Timothy Walsh PRESIDENT & CEO Greg Brenneman EXECUTIVE CHAIRMAN Mark McFadden MANAGING DIRECTOR Patrick McGrath PRINCIPAL Chris Stevenson PRINCIPAL VIEW GROWTH STORIES CCMP III Investments CCMP II Investments Global Fund Investments (realized) Terms of Use and Disclaimers Privacy Notice © 2021 CCMP Capital Advisors, LP. All rights reserved.